Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1967957

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1967957

Global Healthcare Analytical Testing Services Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 111 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The Healthcare Analytical Testing Services Market size is expected to reach USD 2.37 Billion in 2034 from USD 0.93 Billion (2025) growing at a CAGR of 10.97% during 2026-2034.

The healthcare analytical testing services market is buoyed by pharmaceutical and biopharma companies' growing reliance on outsourced analytical capabilities to accelerate development and ensure compliance. Demand spans small-molecule and biologic characterization, stability testing, and complex method development for cell and gene therapies. Outsourcing provides specialized expertise, scalable capacity, and regulatory know-how-critical as product complexity rises and regulatory scrutiny intensifies-making analytical service providers a strategic extension of in-house R&D and QC functions.

Growth drivers include increasing drug development volumes, the surge in biologics and advanced therapies that require specialized assays, and regulatory expectations for robust analytical characterization. Technology investments-high-resolution mass spectrometry, automation, and bioanalytical platforms-are enabling faster, higher-throughput testing. Additionally, commercial labs offering integrated data management, regulatory consulting, and global sample logistics create a one-stop proposition attractive to sponsors seeking faster time-to-market.

Future prospects are strong: the market will likely see sustained double-digit growth as complexity and outsourcing preference continue. Providers that invest in digital platforms, standardized methods, and global footprint will win larger contracts. Strategic differentiation will come from capabilities in novel modalities (cell, gene, RNA therapeutics), real-time analytics, and regulatory intelligence that shortens review cycles-positioning analytical testing services as indispensable partners in the evolving drug-development ecosystem.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Raw Material Testing Services
  • Batch-release Testing Services
  • Physical Characterization Services
  • Microbial Testing
  • Environmental Monitoring Services
  • Air Testing
  • Wastewater/ETP Testing

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Companies
  • Contract Research Organizations

COMPANIES PROFILED

  • Merck KGAA, Charles River Laboratories, WuXi PharmaTech, LabCorp, Eurofins Scientific, Pace Analytical, SGS
  • We can customise the report as per your requirements.
Product Code: VMR11219792

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Raw Material Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Batch-release Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Physical Characterization Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Microbial Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Environmental Monitoring Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Air Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Wastewater/ETP Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Pharmaceutical and Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Merck KGAA
    • 8.2.2 Charles River Laboratories
    • 8.2.3 WuXi PharmaTech
    • 8.2.4 LabCorp
    • 8.2.5 Eurofins Scientific
    • 8.2.6 Pace Analytical
    • 8.2.7 SGS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!